PHG dividend history

March 23, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board, with effect from May 8, 2026.Proposal to re-appoint Roy Jakobs (Dutch/German, 1974) as President/CEO and Chairman and memb

November 4, 2025Q3 2025 Group Highlights Comparable order intake growth 8%Group sales amounted to EUR 4.3 billion, reflecting 3% increase in comparable salesIncome from operations was EUR 330 millionAdjusted EBITA margin increased by 50 basis points to 12.3% of salesOperating cash flow of EUR 327 million, with a free cash flow of EUR 172 millionPhilips reiterates full-year 2025 outlook, with margin now expected at the upper end of the range Roy Jakobs, CEO of Royal Philips:"In this quarter we maintained our momentum, with AI-powered innovations and long-term partnerships making a real difference for patients and consumers. We drove strong order intake and accelerated sales growth, with sus

July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6%Group sales EUR 4.3 billion, reflecting 1% increase in comparable salesIncome from operations EUR 400 millionAdjusted EBITA margin increased 130 bps to 12.4% of salesFree cash flow increased to EUR 230 millionPhilips increases full year 2025 outlook for Adjusted EBITA margin and free cash flow; reiterates comparable sales growth outlook Roy Jakobs, CEO of Royal Philips:"We are focused on driving profitable growth and delivering better care for more people. We built order intake growth momentum, supported by our recently launched AI-powered innovations. Our multi-year agreement with the Indonesian Ministry of Health re

June 5, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that the exchange ratio for the dividend for the year 2024 is 1 new common share for every 23.6353 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 30, June 2, and 3, 2025, of EUR 20.0600 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 22,980,748 new common shares. Shareholders have been given the opportunity to make their choice between a dividend in shares or (subject to certain conditions) in cash. The aggregate cash election

May 6, 2025Q1 2025 Group performance Group sales EUR 4.1 billion, reflecting a 2% decline in comparable sales growth mainly due to China; slightly ahead of company outlook due to Personal Health growth and royalty phasingComparable order intake increased 2% despite China declineIncome from operations increased to EUR 154 millionAdjusted EBITA margin declined 80 bps to 8.6% of sales, driven by sales phasingFree cash outflow of EUR 1,091 million included EUR 1,025 million payment for Philips Respironics recall-related medical monitoring and personal injury settlements in USUpdated full year 2025 outlook for Adjusted EBITA margin and free cash flow; sales outlook remains unchanged Roy Jakobs,

March 24, 2025Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes.As previously announced, the agenda includes: Proposal to appoint Mr Bob White (American, 1962) as a new member of the Supervisory Board, with effect from May 8, 2025.Proposals to re-appoint Ms Indra Nooyi (American, 1955) and Ms Chua Sock Koong (Singaporean, 1957) as members of the Supervisory Board, with effect from May 8, 2025.Proposal to re-appoint Mr Marnix van Ginneken (Dutch, 1973) as a member of the Philips Board of Management, with effect from May 8, 2025.  The agenda fu

February 19, 2025Full Year and Q4 Group performance highlights Sales of EUR 18.0 billion in 2024, comparable sales growth 1%; EUR 5.0 billion in Q4, comparable sales growth 1%, despite double-digit decline in ChinaComparable order intake increased 1% in 2024; up 2% in Q4, despite double-digit decline in ChinaIncome from operations was EUR 529 million in 2024; EUR 199 million in Q4Adjusted EBITA margin increased 90 basis points to 11.5% of sales in 2024; up 60 basis points to 13.5% in Q4Net cash flow from operating activities was EUR 1,569 million in 2024; EUR 1,459 million in Q4Free cash flow was EUR 906 million in 2024; EUR 1,285 million in Q4Finalized Philips Respironics recall-related me

October 28, 2024 Third-quarter highlights Group sales amounted to EUR 4.4 billion, with flat comparable sales growthIncome from operations was EUR 337 millionAdjusted EBITA margin increased by 160 basis points from 10.2% to 11.8% of salesOperating cashflow of EUR 192 million, with a free cashflow of EUR 22 millionComparable order intake decreased by 2%, due to decline in ChinaOutlook for full-year 2024 revised to reflect deteriorated demand in China: comparable sales growth within an updated range 0.5%-1.5%, Adjusted EBITA margin at around 11.5%, the upper end of current range; free cashflow at around EUR 0.9 billion, at lower end of current range Roy Jakobs, CEO of Royal Philips:

July 29, 2024 Second-quarter highlights Group sales amounted to EUR 4.5 billion, with comparable sales growth of 2%Comparable order intake increased by 9%Income from operations EUR 816 million, including EUR 538 million insurance income*)Adjusted EBITA margin increased to 11.1% of salesOperating cash inflow of EUR 89 million, with a free cash outflow of EUR 64 million  Roy Jakobs, CEO of Royal Philips:"I am encouraged by our return to order intake growth this quarter, primarily driven by North America. Within a challenging macro environment we achieved strong margin improvement, supported by our productivity program, solid operational cashflow due to improved working capital m

May 15, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 9, 10 and 13, 2024, of EUR 24.8481 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 30,860,582 new common shares. Distribution of the dividend with delivery of new common shares and settlement of any fractions in cash, will take place from May 16, 2024. Upon distribution, the total i

 March 22, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposals to re-appoint Chairman Feike Sijbesma (Dutch, 1959) and Peter Löscher (Austrian, 1957) as members of the Supervisory Board, with effect from May 7, 2024.Proposal to appoint Charlotte Hanneman (Dutch, 1978) as member of the Board of Management, fulfilling the role of Chief Financial Officer, with effect from October 1, 202

July 24, 2023 Second-quarter highlights Group sales increased to EUR 4.5 billion, with 9% comparable sales growthIncome from operations amounted to EUR 221 million, compared to EUR 11 million in Q2 2022Adjusted EBITA increased to EUR 453 million, or 10.1% of sales, compared to EUR 216 million, or 5.2% of sales, in Q2 2022Order book continued to grow year-on-year, while comparable order intake declined following a high order intake in Q2 2022Operating cash flow improved to EUR 135 million, compared to an outflow of EUR 306 million in Q2 2022Simplification of the operating model and restructuring plans on trackOutlook for full year 2023 raised to mid-single-di

May 17, 2023Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))) today announced that the exchange ratio for the dividend for the year 2022 is 1 new common share for every 22.3906 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 11, 12 and 15, 2023, of EUR 19.0020 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 39,334,938 new common shares. Distribution of the dividend with delivery of new common shares and settlement of any fractions in cash, will take place from May 18, 2023. Upon distribution, the total iss

May 9, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))) announced that today's Annual General Meeting of Shareholders (2023 AGM) has reappointed Abhijit Bhattacharya for a two year's term as member of the Board of Management fulfilling the role of CFO, and reappointed Liz Doherty and David Pyott as members of the Supervisory Board. With these reappointments, the composition of the Supervisory Board committees remains unchanged. Other voting items, such the company's proposed dividend of EUR 0.85 per share over 2022, [1] the proposal to reappoint EY as the company's external auditor for a term of one year starting January 1, 2024, and the proposal to appoint Pr

March 24, 2023  Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2023 and published the agenda with explanatory notes. The agenda of the AGM 2023 includes the recommendation of the Supervisory Board, endorsed by Philips' Chief Executive Officer to the shareholders to re-appoint Abhijit Bhattacharya (Indian, 1961) as member of the Board of Management for an additional period of two years, with effect from May 9, 2023. Mr Bhattacharya has held the positions of Chief Financial Officer and member of the Board of Management since 2015. Additionally, it will be proposed to the sharehol

January 30, 2023 Fourth-quarter highlights Group sales amounted to EUR 5.4 billion, with 3% comparable sales growth driven by component supply improvements, while Philips' supply chain conditions remain challengingComparable order intake decreased 8%, due to lower demand for COVID-19-related products compared to 2021 and company actions to improve the order book margin profileIncome from operations amounted to EUR 171 million, compared to EUR 162 million in Q4 2021Adjusted EBITA of EUR 651 million, or 12.0% of sales, compared to EUR 647 million, or 13.1% of sales, in Q4 2021Operating cash flow was EUR 540 million, compared to EUR 720 million in Q4 2021 Full-year hi

July 25, 2022 Highlights Group sales amounted to EUR 4.2 billion, with a 7% comparable sales decline mainly caused by continued supply shortages and prolonged lockdowns in China, on the back of 9% comparable sales growth in Q2 2021Order book remains strong; comparable order intake increased 1% and includes a 5 percentage-points negative impact related to ChinaIncome from operations amounted to EUR 11 million, compared to EUR 85 million in Q2 2021Adjusted EBITA of EUR 216 million, or 5.2% of sales, compared to EUR 532 million, or 12.6% of sales, in Q2 2021Operating cash flow was an outflow of EUR 306 million, mainly due to temporarily higher inventories, compared to an inflow of EUR 332

June 7, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))) today announced that the exchange ratio for the dividend in shares for the year 2021 has been determined. The exchange ratio is 1 new common share for every 27.3184 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of June 1, 2 and 3, 2022, of EUR 23.1906 and was calculated in a manner that the gross dividend in shares is approximately equal to the gross dividend in cash. Shareholders were given the opportunity to make their choice between cash and shares between May 16, 2022 and June 3, 2022. If no choice was made during this election period, the dividend w

March 28, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))) today convenes the Annual General Meeting of Shareholders (AGM) 2022 and publishes the agenda with explanatory notes. The agenda of the AGM 2022 includes proposals to appoint Mrs. Herna Verhagen and Mr. Sanjay Poonen and to re-appoint Dr. Paul Stoffels and Dr. Marc Harrison as members of the Supervisory Board. The agenda also includes the proposal to re-appoint Ernst & Young Accountants LLP as the company's auditor, as well as a number of recurring items, such as proposals to adopt the company's financial statements and dividend. The AGM will be held virtually on Tuesday May 10, 2022, beginning at 14:00 hour

January 24, 2022 Fourth-quarter highlights Group sales amounted to EUR 4.9 billion, with a 10% comparable sales declineComparable order intake increased 4%, driven by double-digit growth in the Diagnosis & Treatment businessesIncome from continuing operations amounted to EUR 139 million and included an impact of EUR 220 million related to the addition to the Respironics field action provision; income from continuing operations was EUR 508 million in Q4 2020Adjusted EBITA of EUR 647 million, or 13.1% of sales, compared to EUR 995 million, or 19.0% of sales, in Q4 2020Operating cash flow was EUR 720 million, resulting in a free cash flow of EUR 519 million Full-year highlights Grou

June 8, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that the exchange ratio for the dividend in shares for the year 2020 has been determined. The exchange ratio is 1 new common share for every 53.9278 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of June 2, 3 and 4, 2021, of EUR 45.8086 and was calculated in a manner that the gross dividend in shares is approximately equal to the gross dividend in cash. Shareholders were given the opportunity to make their choice between cash and shares between May 12, 2021 and June 4, 2021. If no choice was made during this election period, the dividend w

May 26, 2021 Collaboration takes a Silicon Valley approach to the Quadruple Aim, setting new standard for modern healthcare with end-to-end cloud-based interoperability and innovative AI Amsterdam, the Netherlands and San Francisco, CA – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, and the University of California, San Francisco (UCSF), a world-class biomedical research hub and health system, today announced a partnership to develop technology that will enable a modern, more streamlined experience for patients and set a new standard for healthcare delivery. UCSF will use Philips HealthSuite to oversee the development of technologies that leverage Artificial

May 26, 2021 Collaboration takes a Silicon Valley approach to the Quadruple Aim, setting new standard for modern healthcare with end-to-end cloud-based interoperability and innovative AI Amsterdam, the Netherlands and San Francisco, CA – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, and the University of California, San Francisco (UCSF), a world-class biomedical research hub and health system, today announced a partnership to develop technology that will enable a modern, more streamlined experience for patients and set a new standard for healthcare delivery. UCSF will use Philips HealthSuite to oversee the development of technologies that leverage Artificial

May 6, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))) announced that today's Annual General Meeting of Shareholders (2021 AGM) has re-appointed Mr. Marnix van Ginneken as member of the Board of Management and appointed Mrs. Chua Sock Koong and Mrs. Indra Nooyi as members of the Supervisory Board. The other proposals voted on at the 2021 AGM, including the proposal to pay a dividend of EUR 0.85 per share over 2020, were also adopted. More information about the dividend can be found via this link. More information on the composition of the Board of Management, the Executive Committee and the Supervisory Board can be found here. Philips' 2020 financial statements ar

NEW YORK, April 15, 2021 /PRNewswire/ -- The pandemic is still a very real threat as the number of new cases spiked in the United States once again. CDC's most recent data shows that the seven-day average of new cases is a little more than 64,000 per day, up about 2% from the prior seven-day period Walensky said, per a CNN report. Hospital admissions also continue to increase. The most recent seven-day average, about 5,300 admissions per day, is up about 7% from the previous seven-day period. Dr. Abdul El-Sayed, a former health commissioner for Detroit, explained according to a report by CNN, that "vaccines don't work until they hit people's arms - and we just don't have enough vaccinations

March 22, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today convenes the 2021 Annual General Meeting of Shareholders (AGM) and publishes the agenda with explanatory notes. The agenda of the 2021 AGM includes proposals to reappoint Mr. Marnix van Ginneken as member of the Board of Management and to appoint Mrs. Chua Sock Koong and Mrs. Indra Nooyi as members of the Supervisory Board. The agenda also includes a number of recurring items, such as proposals to adopt the company’s financial statements and dividend. The AGM will be held on Thursday May 6, 2021, beginning at 14:00 hours CET. To protect the health and safety of all participants in connection with COVI

January 25, 2021 Fourth-quarter highlights•        Sales amounted to EUR 6.0 billion, with 7% comparable sales growth•        Comparable order intake increased 7%•        Income from continuing operations increased to EUR 608 million, compared to EUR 550 million in Q4 2019•        Adjusted EBITA margin increased to 19.0% of sales, compared to 17.9% of sales in Q4 2019•        Income from operations improved to EUR 795 million, compared to EUR 730 million in Q4 2019•        EPS from continuing operations (diluted) amounted to EUR 0.66; Adjusted EPS increased to EUR 0.94, compared to EUR 0.83 in Q4 2019•        Operating cash flow improved to EUR 1,305 million, compared to EUR 1,271 mill